Narayana S Ambati, MD
Urology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 58 years
- Graduated 1968
Offices
1 location · Urology Associates of Central California Medical Group Inc · 11 clinicians in this group
Looking this up.
Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ambati’s office at (559) 321-2800 to ask if they take your plan before you enroll.
California Medical Board record
Surgery centers they own
- Urology Associates of Central California, Inc dba Chestnut Surgery Center, LLCAmbulatory Surgery Center · Fresno, CA16.7% owner since 1998 · accredited by AAAHCAccreditation Renewed5 inspections, 3 with deficiencies · last 2026-01-29
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$361,525
Medicare paid this office $361,525 for 917 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 592 | $102,318 | $96 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 37 | $30,464 | None |
| Leuprolide injectable, camcevi, 1 mg | 12 | $28,308 | None |
| Short return visit (20+ min) | 315 | $24,161 | $69 |
| Diagnostic exam of bladder and urethra using an endoscope | 97 | $22,290 | $192 |
See all 32 services
| Return visit (30+ min) | 592 | $102,318 | $96 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 37 | $30,464 | None |
| Leuprolide injectable, camcevi, 1 mg | 12 | $28,308 | None |
| Short return visit (20+ min) | 315 | $24,161 | $69 |
| Diagnostic exam of bladder and urethra using an endoscope | 97 | $22,290 | $192 |
| New patient visit (45+ min) | 112 | $13,271 | $118 |
| Ultrasound measurement of bladder capacity after voiding | 740 | $12,439 | $9 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 589 | $11,380 | $13 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 35 | $7,982 | $51 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 25 | $6,100 | $49 |
| Ct scan of abdomen and pelvis before and after contrast | 23 | $6,026 | $262 |
| X-ray of body plane | 61 | $5,924 | $67 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 33 | $3,939 | $39 |
| Dilation of urethra using an endoscope | 11 | $3,661 | $261 |
| Insertion of needle into vein for collection of blood sample | 320 | $3,304 | $8 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 51 | $2,631 | $29 |
| X-ray of abdomen, 1 view | 62 | $2,296 | $23 |
| New patient visit (30+ min) | 26 | $2,263 | $87 |
| Manual urinalysis test with examination using microscope, automated | 501 | $2,226 | $3 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $2,042 | $39 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $1,871 | $110 |
| Simple insertion of temporary bladder tube | 16 | $1,469 | $49 |
| Ultrasound scan of pelvic region through rectum | 12 | $1,406 | $117 |
| Complete ultrasound scan behind abdominal cavity | 17 | $1,368 | $80 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $1,301 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,088 | $73 |
| Injection of drug or substance under skin or into muscle | 32 | $930 | $11 |
| Cell examination of specimen, concentration technique | 18 | $562 | $31 |
| Short return visit | 12 | $555 | $46 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $554 | $46 |
| Automated urinalysis test | 201 | $507 | $2 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 23 | $237 | $0 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | 690 | 625 | 1,077 | 934 | 919 | 1,375 |
| Diagnostic exam of bladder and urethra using an endoscope | 153 | 125 | 146 | 152 | 125 | 116 |
| Simple insertion of temporary bladder tube | 55 | 27 | 20 | 25 | 24 | 30 |
| Electronic assessment of bladder emptying | 36 | 28 | 23 | 16 | 20 | – |
| Instillation of anti-cancer drug into bladder | 40 | 27 | 19 | – | 34 | – |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 26 | 20 | 15 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
917 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 16% · Women 20% · Also on Medicaid 22% · Health risk score 1.27. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 39% · Chronic kidney disease 34% · Cancer 28% · Heart failure 20% · Atrial fibrillation 19% · COPD 13% · Depression 13% · Dementia 7% · Stroke 7%.
The office billed $1,115,887, Medicare allowed $469,757 and paid $361,525; for 26,255 services of 77 kinds; $85,961 of it was for drugs given in the office and $275,564 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 917 | 26,255 | 75 | 1.27 | $1,115,887 | $361,525 |
| 2023 | 927 | 18,411 | 75 | 1.25 | $894,979 | $297,105 |
| 2022 | 950 | 17,672 | 75 | 1.23 | $943,278 | $322,608 |
| 2021 | 983 | 15,321 | 75 | 1.32 | $1,078,048 | $378,891 |
| 2020 | 1,035 | 14,618 | 75 | 1.45 | $1,058,234 | $342,906 |
| 2019 | 1,245 | 19,097 | 75 | 1.48 | $1,266,739 | $410,534 |
| 2018 | 1,272 | 20,871 | 74 | 1.51 | $1,374,346 | $455,740 |
| 2017 | 1,214 | 24,042 | 74 | 1.59 | $1,582,730 | $509,559 |
| 2016 | 1,104 | 26,457 | 74 | 1.47 | $1,431,199 | $478,859 |
| 2015 | 1,095 | 30,297 | 74 | 1.45 | $1,251,202 | $411,691 |
| 2014 | 1,264 | 23,140 | 74 | 1.35 | $1,544,020 | $502,955 |
| 2013 | 1,063 | 22,620 | 74 | 1.37 | $1,472,262 | $494,017 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 28 services
| Return visit (30+ min) | 627 | $101,058 | $94 |
| Diagnostic exam of bladder and urethra using an endoscope | 105 | $24,997 | $200 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 30 | $21,443 | None |
| New patient visit (45+ min) | 168 | $20,075 | $119 |
| Short return visit (20+ min) | 149 | $11,709 | $69 |
| Ct scan of abdomen and pelvis before and after contrast | 28 | $8,251 | $295 |
| X-ray of body plane | 69 | $8,235 | $71 |
| Ultrasound measurement of bladder capacity after voiding | 574 | $7,897 | $9 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 15 | $4,544 | $303 |
| Insertion of needle into vein for collection of blood sample | 351 | $3,701 | $8 |
| Manual urinalysis test with examination using microscope, automated | 592 | $3,342 | $3 |
| Ct scan of abdomen and pelvis without contrast | 19 | $3,139 | $157 |
| X-ray of abdomen, 1 view | 69 | $2,815 | $23 |
| Bcg live intravesical instillation, 1 mg | 11 | $2,715 | None |
| Insertion of device into abdomen with pressure and urine flow rate study | 17 | $2,706 | $159 |
| Instillation of anti-cancer drug into bladder | 15 | $2,380 | $70 |
| Complete ultrasound scan behind abdominal cavity | 22 | $1,880 | $85 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 38 | $1,684 | $28 |
| Ultrasound scan of pelvic region through rectum | 14 | $1,646 | $118 |
| Simple insertion of temporary bladder tube | 15 | $1,256 | $52 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,127 | $75 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $1,034 | $47 |
| Cell examination of specimen, concentration technique | 23 | $848 | $34 |
| Automated urinalysis test | 188 | $481 | $2 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 17 | $455 | $27 |
| Injection of drug or substance under skin or into muscle | 20 | $436 | $11 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 29 | $345 | $0 |
| Electronic assessment of bladder emptying | 20 | $113 | $6 |
2022: 36 services
| Return visit (30+ min) | 691 | $115,537 | $95 |
| Diagnostic exam of bladder and urethra using an endoscope | 128 | $31,593 | $208 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 31 | $26,986 | None |
| New patient visit (45+ min) | 174 | $20,933 | $120 |
| Ct scan of abdomen and pelvis before and after contrast | 36 | $11,496 | $311 |
| Short return visit (20+ min) | 147 | $11,082 | $67 |
| X-ray of body plane | 74 | $8,350 | $73 |
| Ultrasound measurement of bladder capacity after voiding | 566 | $7,784 | $8 |
| Manual urinalysis test with examination using microscope, automated | 646 | $3,817 | $3 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $3,691 | $336 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $3,449 | $314 |
| X-ray of abdomen, 1 view | 74 | $2,875 | $24 |
| Complete ultrasound scan behind abdominal cavity | 28 | $2,217 | $79 |
| Ultrasound scan of pelvic region through rectum | 16 | $1,766 | $110 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $1,734 | $158 |
| Insertion of needle into vein for collection of blood sample | 407 | $1,629 | $3 |
| Psa (prostate specific antigen) measurement, total | 88 | $1,618 | $18 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 35 | $1,614 | $27 |
| Cell examination of specimen, concentration technique | 43 | $1,395 | $31 |
| Unclassified drugs | 12 | $1,268 | None |
| Simple insertion of temporary bladder tube | 16 | $1,256 | $50 |
| Telephone medical discussion with physician, 5-10 minutes | 27 | $1,229 | $46 |
| Blood test, basic group of blood chemicals (calcium, total) | 100 | $846 | $8 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $839 | $65 |
| Injection of drug or substance under skin or into muscle | 23 | $602 | $12 |
| Testosterone (hormone) level, total | 14 | $361 | $26 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 37 | $356 | $0 |
| Automated urinalysis test | 126 | $291 | $2 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $272 | $25 |
| Bacterial colony count, urine | 32 | $258 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 18 | $140 | $8 |
| Bacterial culture for aerobic isolates | 13 | $105 | $8 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 13 | $97 | $7 |
| Electronic assessment of bladder emptying | 16 | $87 | $5 |
| Injection, tobramycin sulfate, up to 80 mg | 11 | $32 | None |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $26 | None |
2021: 40 services
| Return visit (30+ min) | 607 | $98,752 | $103 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 32 | $29,186 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 127 | $28,307 | $194 |
| Short return visit (20+ min) | 374 | $24,485 | $56 |
| Injection, denosumab, 1 mg | 13 | $23,522 | None |
| New patient visit (45+ min) | 155 | $20,283 | $131 |
| Ct scan of abdomen and pelvis before and after contrast | 46 | $14,230 | $309 |
| X-ray of body plane | 88 | $10,300 | $75 |
| Psa (prostate specific antigen) measurement, total | 360 | $9,422 | $18 |
| Ultrasound measurement of bladder capacity after voiding | 654 | $8,844 | $8 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $6,321 | $575 |
| Blood test, basic group of blood chemicals (calcium, total) | 401 | $4,741 | $8 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 15 | $4,652 | $310 |
| Ct scan of abdomen and pelvis without contrast | 23 | $4,097 | $164 |
| Complete ultrasound scan behind abdominal cavity | 39 | $3,708 | $95 |
| X-ray of abdomen, 1 view | 88 | $3,278 | $23 |
| New patient visit (60+ min) | 19 | $3,059 | $161 |
| Ultrasound scan of pelvic region through rectum | 26 | $3,004 | $111 |
| Biopsy of prostate gland | 14 | $2,971 | $212 |
| Manual urinalysis test with examination using microscope, automated | 557 | $2,726 | $3 |
| Testosterone (hormone) level, total | 52 | $2,039 | $26 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 13 | $1,937 | $149 |
| Bacterial colony count, urine | 181 | $1,898 | $8 |
| Insertion of needle into vein for collection of blood sample | 422 | $1,794 | $3 |
| Cell examination of specimen, concentration technique | 50 | $1,674 | $33 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 33 | $1,639 | $27 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $1,547 | $59 |
| Instillation of anti-cancer drug into bladder | 14 | $1,432 | $75 |
| Unclassified drugs | 12 | $1,166 | None |
| Simple insertion of temporary bladder tube | 13 | $1,034 | $52 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 102 | $1,018 | $8 |
| New patient visit (30+ min) | 23 | $933 | $41 |
| Bacterial culture for aerobic isolates | 67 | $800 | $8 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $753 | $44 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 67 | $741 | $7 |
| Automated urinalysis test | 201 | $536 | $2 |
| Liver function blood test panel | 41 | $531 | $8 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 49 | $454 | $0 |
| Injection of drug or substance under skin or into muscle | 23 | $416 | $12 |
| Electronic assessment of bladder emptying | 23 | $139 | $6 |
2020: 41 services
| Short return visit (20+ min) | 721 | $69,186 | $57 |
| Injection, denosumab, 1 mg | 18 | $42,776 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 38 | $41,630 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 103 | $22,212 | $178 |
| New patient visit (30+ min) | 168 | $13,383 | $80 |
| Return visit (30+ min) | 133 | $12,876 | $85 |
| Ct scan of abdomen and pelvis before and after contrast | 32 | $9,675 | $302 |
| Psa (prostate specific antigen) measurement, total | 311 | $7,526 | $18 |
| X-ray of body plane | 59 | $7,048 | $78 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $5,859 | $533 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 20 | $5,848 | $292 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 16 | $5,324 | $205 |
| Ultrasound measurement of bladder capacity after voiding | 459 | $5,283 | $8 |
| Ultrasound scan of pelvic region through rectum | 33 | $3,898 | $118 |
| Blood test, basic group of blood chemicals (calcium, total) | 342 | $3,779 | $8 |
| Telephone medical discussion with physician, 11-20 minutes | 61 | $3,739 | $60 |
| Bcg live intravesical instillation, 1 mg | 12 | $2,790 | None |
| Biopsy of prostate gland | 15 | $2,645 | $176 |
| Manual urinalysis test with examination using microscope, automated | 468 | $2,281 | $3 |
| Complete ultrasound scan behind abdominal cavity | 32 | $2,152 | $67 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 15 | $2,078 | $139 |
| X-ray of abdomen, 1 view | 59 | $2,072 | $22 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $1,958 | $26 |
| Instillation of anti-cancer drug into bladder | 13 | $1,930 | $71 |
| Bacterial colony count, urine | 151 | $1,668 | $8 |
| Testosterone (hormone) level, total | 40 | $1,640 | $26 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $1,551 | $141 |
| Short return visit | 39 | $1,504 | $37 |
| Automated urinalysis test | 499 | $1,474 | $2 |
| Insertion of needle into vein for collection of blood sample | 370 | $1,407 | $3 |
| Cell examination of specimen, concentration technique | 40 | $1,295 | $29 |
| Simple insertion of temporary bladder tube | 19 | $1,239 | $46 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 75 | $764 | $8 |
| Bacterial culture for aerobic isolates | 60 | $688 | $8 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 60 | $637 | $7 |
| Injection of drug or substance under skin or into muscle | 26 | $509 | $12 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $426 | $39 |
| Liver function blood test panel | 29 | $382 | $8 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $316 | $29 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 33 | $291 | $0 |
| Electronic assessment of bladder emptying | 28 | $170 | $6 |
2019: 45 services
| Short return visit (20+ min) | 896 | $89,197 | $55 |
| Injection, denosumab, 1 mg | 18 | $39,217 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 41 | $35,491 | None |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 19 | $29,784 | $1,568 |
| Diagnostic exam of bladder and urethra using an endoscope | 120 | $23,384 | $153 |
| New patient visit (30+ min) | 193 | $15,519 | $80 |
| Ct scan of abdomen and pelvis before and after contrast | 44 | $13,145 | $292 |
| Return visit (30+ min) | 145 | $12,934 | $81 |
| Psa (prostate specific antigen) measurement, total | 382 | $10,944 | $20 |
| X-ray of body plane | 68 | $7,548 | $73 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 26 | $7,133 | $274 |
| Ultrasound measurement of bladder capacity after voiding | 510 | $6,670 | $10 |
| Blood test, basic group of blood chemicals (calcium, total) | 415 | $5,344 | $9 |
| Complete ultrasound scan behind abdominal cavity | 63 | $5,255 | $82 |
| Biopsy of prostate gland | 25 | $5,113 | $205 |
| Ultrasound scan of pelvic region through rectum | 46 | $5,032 | $109 |
| Shock wave crushing of kidney stones | 11 | $4,956 | $451 |
| Automated urinalysis test | 1,050 | $4,804 | $2 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 24 | $4,085 | $170 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $3,666 | $306 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 16 | $3,195 | $188 |
| Long return visit (40+ min) | 27 | $3,058 | $109 |
| Bacterial colony count, urine | 237 | $2,973 | $9 |
| Instillation of anti-cancer drug into bladder | 16 | $2,834 | $71 |
| Simple insertion of temporary bladder tube | 32 | $2,653 | $48 |
| Ct scan of abdomen and pelvis without contrast | 14 | $2,386 | $159 |
| X-ray of abdomen, 1 view | 67 | $2,218 | $21 |
| Insertion of needle into vein for collection of blood sample | 455 | $1,971 | $3 |
| Short return visit | 49 | $1,887 | $36 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $1,781 | $25 |
| Testosterone (hormone) level, total | 39 | $1,557 | $27 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $1,306 | $119 |
| Bacterial culture for aerobic isolates | 100 | $1,299 | $9 |
| Cell examination of specimen, concentration technique | 39 | $1,196 | $29 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 100 | $1,110 | $7 |
| Injection of drug or substance under skin or into muscle | 51 | $1,083 | $14 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 88 | $915 | $8 |
| Dxa bone density measurement of hip, pelvis, spine | 11 | $451 | $41 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 45 | $411 | $0 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $370 | $28 |
| Liver function blood test panel | 28 | $304 | $9 |
| Examination of archival tissue for genetic analysis | 14 | $275 | $20 |
| Manual urinalysis test with examination using microscope, automated | 49 | $245 | $3 |
| Electronic assessment of bladder emptying | 36 | $216 | $6 |
| Injection, garamycin, gentamicin, up to 80 mg | 22 | $41 | None |
2018: 50 services
| Short return visit (20+ min) | 913 | $86,191 | $52 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 47 | $40,044 | None |
| Other procedure on urinary system | 22 | $33,837 | $1,538 |
| Injection, denosumab, 1 mg | 15 | $30,115 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 163 | $25,395 | $131 |
| New patient visit (30+ min) | 246 | $19,217 | $78 |
| Ultrasound measurement of bladder capacity after voiding | 882 | $18,950 | $12 |
| Return visit (30+ min) | 208 | $18,221 | $79 |
| Ct scan of abdomen and pelvis before and after contrast | 55 | $15,029 | $268 |
| Psa (prostate specific antigen) measurement, total | 397 | $12,335 | $22 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 20 | $11,556 | $578 |
| X-ray of body plane | 93 | $8,886 | $72 |
| Complete ultrasound scan behind abdominal cavity | 90 | $7,767 | $83 |
| Blood test, basic group of blood chemicals (calcium, total) | 467 | $6,334 | $10 |
| Long return visit (40+ min) | 53 | $6,102 | $111 |
| Automated urinalysis test | 1,077 | $5,658 | $3 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 26 | $5,411 | $208 |
| Shock wave crushing of kidney stones | 11 | $5,156 | $469 |
| Biopsy of prostate gland | 25 | $4,729 | $189 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 14 | $4,046 | $289 |
| Bacterial colony count, urine | 280 | $4,021 | $10 |
| Ultrasound scan of pelvic region through rectum | 43 | $3,462 | $81 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 15 | $3,035 | $190 |
| Bcg (intravesical) per instillation | 14 | $2,912 | None |
| X-ray of abdomen, 1 view | 97 | $2,894 | $21 |
| Simple change of bladder tube | 15 | $2,886 | $76 |
| Simple insertion of temporary bladder tube | 33 | $2,680 | $51 |
| Ct scan of abdomen and pelvis without contrast | 16 | $2,331 | $146 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 13 | $2,268 | $162 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 51 | $2,257 | $25 |
| Bacterial culture for aerobic isolates | 151 | $2,228 | $10 |
| Instillation of anti-cancer drug into bladder | 16 | $2,183 | $70 |
| Insertion of needle into vein for collection of blood sample | 503 | $2,099 | $3 |
| Insertion of device into abdomen with pressure and urine flow rate study | 20 | $1,920 | $96 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 151 | $1,902 | $8 |
| Testosterone (hormone) level, total | 43 | $1,565 | $31 |
| Simple bladder irrigation and/or instillation | 11 | $1,337 | $61 |
| Injection of drug or substance under skin or into muscle | 50 | $1,209 | $17 |
| Short return visit | 32 | $1,203 | $33 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 102 | $1,101 | $9 |
| Cell examination of specimen, concentration technique | 32 | $978 | $29 |
| Diagnostic exam of bladder and urethra using an endoscope | 17 | $944 | $56 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 21 | $637 | $30 |
| Dxa bone density measurement of hip, pelvis, spine | 13 | $576 | $44 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 56 | $560 | $0 |
| Examination of archival tissue for genetic analysis | 16 | $316 | $20 |
| Liver function blood test panel | 26 | $268 | $10 |
| Manual urinalysis test with examination using microscope, automated | 33 | $220 | $4 |
| Electronic assessment of bladder emptying | 22 | $144 | $7 |
| Injection, garamycin, gentamicin, up to 80 mg | 27 | $39 | None |
2017: 51 services
| Short return visit (20+ min) | 825 | $74,917 | $49 |
| Destruction of prostate tissue using radiofrequency induced heat | 34 | $51,663 | $1,520 |
| Injection, denosumab, 1 mg | 25 | $48,176 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 41 | $43,601 | None |
| Return visit (30+ min) | 418 | $41,785 | $80 |
| Ultrasound measurement of bladder capacity after voiding | 840 | $23,723 | $14 |
| Diagnostic exam of bladder and urethra using an endoscope | 145 | $21,095 | $126 |
| New patient visit (30+ min) | 228 | $17,621 | $77 |
| Psa (prostate specific antigen) measurement, total | 439 | $16,614 | $25 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $9,914 | $620 |
| Ct scan of abdomen and pelvis before and after contrast | 43 | $8,366 | $195 |
| Blood test, basic group of blood chemicals (calcium, total) | 501 | $8,169 | $11 |
| Shock wave crushing of kidney stones | 17 | $7,918 | $440 |
| X-ray of body plane | 59 | $6,960 | $69 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 27 | $6,537 | $242 |
| Automated urinalysis test | 1,008 | $6,311 | $3 |
| Biopsy of prostate gland | 27 | $5,192 | $185 |
| Dilation of urethra using an endoscope | 23 | $5,064 | $211 |
| Long return visit (40+ min) | 45 | $5,022 | $107 |
| Bacterial colony count, urine | 277 | $4,883 | $11 |
| Complete ultrasound scan behind abdominal cavity | 76 | $4,523 | $57 |
| Ultrasound scan of pelvic region through rectum | 54 | $4,241 | $76 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 14 | $3,981 | $181 |
| Simple change of bladder tube | 15 | $3,862 | $68 |
| Simple insertion of temporary bladder tube | 40 | $3,774 | $49 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $3,098 | $258 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 47 | $2,498 | $25 |
| Bacterial culture for aerobic isolates | 130 | $2,487 | $11 |
| Insertion of needle into vein for collection of blood sample | 536 | $2,420 | $3 |
| Testosterone (hormone) level, total | 50 | $2,325 | $35 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 130 | $2,123 | $9 |
| Injection of drug or substance under skin or into muscle | 76 | $2,100 | $20 |
| X-ray of abdomen, single view | 62 | $2,030 | $17 |
| Insertion of stent in ureter using an endoscope | 14 | $1,564 | $92 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 114 | $1,453 | $10 |
| Cell examination of specimen, concentration technique | 48 | $1,432 | $27 |
| Ct scan of abdomen and pelvis without contrast | 13 | $1,183 | $91 |
| Ultrasonic guidance for needle placement | 22 | $1,090 | $47 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $977 | $89 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $690 | $63 |
| Short return visit | 20 | $645 | $32 |
| Manual urinalysis test with examination using microscope, automated | 63 | $494 | $4 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 44 | $430 | $0 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $380 | $27 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $326 | $27 |
| Ultrasound scan of scrotum | 11 | $305 | $28 |
| Examination of archival tissue for genetic analysis | 15 | $275 | $18 |
| Liver function blood test panel | 31 | $270 | $7 |
| Electronic assessment of bladder emptying | 14 | $99 | $7 |
| Injection, garamycin, gentamicin, up to 80 mg | 33 | $53 | None |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $19 | None |
2016: 45 services
| Short return visit (20+ min) | 852 | $89,369 | $53 |
| Injection, denosumab, 1 mg | 23 | $49,081 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 31 | $38,645 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 144 | $27,305 | $166 |
| Ultrasound measurement of bladder capacity after voiding | 725 | $18,941 | $15 |
| Return visit (30+ min) | 173 | $15,769 | $77 |
| Psa (prostate specific antigen) measurement, total | 363 | $13,341 | $25 |
| New patient visit (30+ min) | 168 | $13,193 | $79 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 17 | $11,809 | $695 |
| Shock wave crushing of kidney stones | 11 | $6,739 | $421 |
| Blood test, basic group of blood chemicals (calcium, total) | 402 | $6,638 | $11 |
| Ct scan of abdomen and pelvis before and after contrast | 28 | $5,851 | $209 |
| Automated urinalysis test | 933 | $5,718 | $3 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 18 | $5,615 | $312 |
| Long return visit (40+ min) | 48 | $5,504 | $112 |
| X-ray of body plane | 49 | $5,312 | $67 |
| Bacterial colony count, urine | 260 | $4,057 | $11 |
| Simple change of bladder tube | 18 | $3,917 | $73 |
| Cell examination of specimen, concentration technique | 78 | $3,464 | $38 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $3,426 | $285 |
| Simple insertion of temporary bladder tube | 38 | $3,382 | $57 |
| Biopsy of prostate gland | 17 | $2,961 | $174 |
| Instillation of anti-cancer drug into bladder | 12 | $2,609 | $90 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 14 | $2,167 | $144 |
| Insertion of needle into vein for collection of blood sample | 469 | $2,072 | $3 |
| Injection of drug or substance under skin or into muscle | 49 | $2,042 | $20 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 34 | $2,008 | $27 |
| Complete ultrasound scan behind abdominal cavity | 28 | $1,928 | $60 |
| Ultrasound scan of pelvic region through rectum | 22 | $1,854 | $74 |
| Bacterial culture for aerobic isolates | 112 | $1,748 | $11 |
| Biopsy of bladder using an endoscope | 14 | $1,573 | $112 |
| Insertion of stent in ureter using an endoscope | 11 | $1,532 | $102 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 112 | $1,498 | $9 |
| X-ray of abdomen, single view | 50 | $1,488 | $17 |
| Ct scan of abdomen and pelvis without contrast | 13 | $1,106 | $74 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 85 | $1,103 | $10 |
| Testosterone (hormone) level, total | 25 | $1,069 | $34 |
| Ultrasonic guidance for needle placement | 18 | $1,063 | $51 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $1,034 | $94 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $967 | $81 |
| Insertion of temporary bladder tube | 17 | $810 | $43 |
| Dxa bone density measurement of hip, pelvis, spine | 12 | $521 | $43 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 29 | $278 | $0 |
| Manual urinalysis test with examination using microscope, automated | 27 | $111 | $4 |
| Electronic assessment of bladder emptying | 12 | $79 | $7 |
2015: 45 services
| Short return visit (20+ min) | 866 | $96,496 | $52 |
| Injection, denosumab, 1 mg | 28 | $43,780 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 38 | $41,585 | None |
| Return visit (30+ min) | 288 | $31,165 | $81 |
| Diagnostic exam of bladder and urethra using an endoscope | 126 | $23,177 | $162 |
| Ultrasound measurement of bladder capacity after voiding | 723 | $20,044 | $14 |
| Psa (prostate specific antigen) measurement, total | 428 | $16,168 | $24 |
| New patient visit (30+ min) | 139 | $10,946 | $79 |
| Blood test, basic group of blood chemicals (calcium, total) | 473 | $7,743 | $11 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 17 | $6,881 | $382 |
| Ct scan of abdomen and pelvis before and after contrast | 30 | $6,304 | $210 |
| Automated urinalysis test | 905 | $5,914 | $3 |
| Bacterial colony count, urine | 319 | $5,668 | $11 |
| Simple insertion of temporary bladder tube | 39 | $4,834 | $57 |
| Cell examination of specimen, concentration technique | 83 | $4,481 | $47 |
| X-ray of body plane | 40 | $4,102 | $71 |
| Simple change of bladder tube | 15 | $4,052 | $72 |
| Biopsy of prostate gland | 17 | $3,213 | $179 |
| Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | 12 | $3,190 | $245 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 14 | $2,800 | $200 |
| Long return visit (40+ min) | 26 | $2,789 | $107 |
| Bacterial culture for aerobic isolates | 153 | $2,772 | $11 |
| Injection of drug or substance under skin or into muscle | 69 | $2,465 | $20 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $2,408 | $27 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 153 | $2,366 | $9 |
| Insertion of needle into vein for collection of blood sample | 490 | $2,203 | $3 |
| New patient visit (45+ min) | 16 | $2,117 | $132 |
| Complete ultrasound scan behind abdominal cavity | 28 | $1,748 | $62 |
| Ultrasound scan of pelvic region through rectum | 17 | $1,482 | $78 |
| Testosterone (hormone) level, total | 26 | $1,446 | $34 |
| Insertion of stent in ureter using an endoscope | 12 | $1,419 | $95 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 103 | $1,327 | $10 |
| Ct scan of abdomen and pelvis without contrast | 13 | $1,317 | $94 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $1,286 | $86 |
| X-ray of abdomen, single view | 43 | $1,207 | $18 |
| Ultrasonic guidance for needle placement | 18 | $1,040 | $50 |
| Dxa bone density measurement of hip, pelvis, spine | 12 | $516 | $43 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 32 | $386 | $0 |
| Short return visit | 13 | $373 | $29 |
| Manual urinalysis test with examination using microscope, automated | 78 | $367 | $4 |
| Liver function blood test panel | 19 | $243 | $10 |
| Manual urinalysis test with examination using microscope, non-automated | 53 | $233 | $4 |
| Injection, testosterone cypionate, 1 mg | 13 | $232 | None |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $32 | None |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $24 | None |
2014: 54 services
| Short return visit (20+ min) | 966 | $111,519 | $52 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 43 | $44,012 | None |
| Injection, denosumab, 1 mg | 25 | $36,422 | None |
| Return visit (30+ min) | 291 | $29,042 | $79 |
| Diagnostic exam of bladder and urethra using an endoscope | 141 | $25,274 | $157 |
| Ultrasound measurement of bladder capacity after voiding | 785 | $23,427 | $15 |
| Psa (prostate specific antigen) measurement, total | 482 | $19,011 | $25 |
| New patient visit (30+ min) | 148 | $12,481 | $84 |
| Blood test, basic group of blood chemicals (calcium, total) | 584 | $9,782 | $11 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 13 | $8,103 | $623 |
| X-ray of body plane | 54 | $7,805 | $80 |
| Ct scan of abdomen and pelvis before and after contrast | 34 | $7,724 | $227 |
| Bacterial colony count, urine | 410 | $7,501 | $11 |
| Shock wave crushing of kidney stones | 15 | $7,327 | $458 |
| Complete ultrasound scan behind abdominal cavity | 83 | $6,659 | $78 |
| Automated urinalysis test | 1,004 | $6,457 | $3 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 16 | $6,334 | $396 |
| Injection, degarelix, 1 mg | 11 | $6,322 | None |
| Cell examination of specimen, concentration technique | 128 | $6,108 | $42 |
| Simple insertion of temporary bladder tube | 41 | $5,203 | $57 |
| Simple change of bladder tube | 22 | $4,658 | $73 |
| Long return visit (40+ min) | 43 | $4,128 | $94 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 48 | $3,184 | $26 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $3,111 | $283 |
| Bacterial culture for aerobic isolates | 165 | $3,093 | $11 |
| Dilation of urethra using an endoscope | 13 | $3,084 | $220 |
| Injection of drug or substance under skin or into muscle | 91 | $2,950 | $20 |
| Biopsy of prostate gland | 16 | $2,819 | $176 |
| Ct scan of abdomen and pelvis without contrast | 26 | $2,727 | $105 |
| Insertion of needle into vein for collection of blood sample | 589 | $2,709 | $3 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 165 | $2,620 | $9 |
| Biopsy of bladder using an endoscope | 19 | $2,417 | $110 |
| Insertion of stent in ureter using an endoscope | 14 | $2,417 | $115 |
| Testosterone (hormone) level, total | 49 | $2,315 | $34 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 11 | $2,292 | $191 |
| X-ray of abdomen, single view | 56 | $2,283 | $20 |
| Short return visit | 52 | $1,828 | $33 |
| Ultrasound scan of pelvic region through rectum | 20 | $1,785 | $74 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 141 | $1,726 | $10 |
| Ultrasonic guidance for needle placement | 19 | $1,479 | $59 |
| Instillation of anti-cancer drug into bladder | 11 | $1,345 | $79 |
| Insertion of device into abdomen with pressure and urine flow rate study | 13 | $1,203 | $93 |
| Manual urinalysis test with examination using microscope, non-automated | 212 | $1,134 | $4 |
| New patient visit (45+ min) | 11 | $1,122 | $102 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | $1,114 | $80 |
| Dxa bone density measurement of hip, pelvis, spine | 18 | $932 | $52 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 35 | $484 | $0 |
| Liver function blood test panel | 19 | $287 | $10 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 18 | $213 | None |
| Manual urinalysis test with examination using microscope, automated | 32 | $136 | $4 |
| Electronic assessment of bladder emptying | 11 | $71 | $6 |
| Injection, garamycin, gentamicin, up to 80 mg | 19 | $45 | None |
| Injection, ceftriaxone sodium, per 250 mg | 17 | $36 | None |
| Injection, ketorolac tromethamine, per 15 mg | 16 | $19 | None |
2013: 52 services
| Short return visit (20+ min) | 897 | $111,022 | $53 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 41 | $49,295 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 164 | $30,128 | $162 |
| Injection, denosumab, 1 mg | 24 | $24,662 | None |
| Ultrasound measurement of bladder capacity after voiding | 655 | $18,413 | $15 |
| Psa (prostate specific antigen) measurement, total | 449 | $18,384 | $25 |
| Ct scan of abdomen and pelvis before and after contrast | 63 | $17,060 | $267 |
| Return visit (30+ min) | 144 | $14,588 | $83 |
| New patient visit (30+ min) | 131 | $10,853 | $83 |
| Blood test, basic group of blood chemicals (calcium, total) | 511 | $8,948 | $11 |
| Complete ultrasound scan behind abdominal cavity | 105 | $8,727 | $81 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 13 | $8,471 | $652 |
| Pathology examination of tissue using a microscope, intermediate complexity | 22 | $7,602 | $28 |
| Bacterial colony count, urine | 380 | $6,903 | $11 |
| Automated urinalysis test | 909 | $6,660 | $3 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 23 | $6,544 | $285 |
| X-ray of body plane | 61 | $6,347 | $76 |
| New patient visit (45+ min) | 41 | $5,296 | $129 |
| Simple insertion of temporary bladder tube | 35 | $4,497 | $58 |
| Cell examination of specimen, concentration technique | 79 | $4,105 | $44 |
| Ultrasonic guidance for needle placement | 21 | $4,053 | $176 |
| Insertion of device into abdomen with pressure and urine flow rate study | 35 | $3,325 | $95 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 45 | $3,269 | $27 |
| Biopsy of prostate gland | 20 | $3,252 | $163 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 12 | $3,195 | $266 |
| Long return visit (40+ min) | 25 | $3,135 | $116 |
| Bacterial culture for aerobic isolates | 148 | $2,889 | $11 |
| Biopsy of bladder using an endoscope | 22 | $2,845 | $105 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 35 | $2,836 | $81 |
| Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | 11 | $2,790 | $233 |
| Testosterone (hormone) level, total | 45 | $2,591 | $35 |
| Insertion of needle into vein for collection of blood sample | 531 | $2,526 | $3 |
| Injection of drug or substance under skin or into muscle | 61 | $2,491 | $21 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 148 | $2,457 | $9 |
| Short return visit | 55 | $1,930 | $33 |
| X-ray of abdomen, single view | 63 | $1,784 | $19 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 123 | $1,718 | $11 |
| Ultrasound scan of pelvic region through rectum | 27 | $1,644 | $61 |
| Insertion of stent in ureter using an endoscope | 11 | $1,361 | $97 |
| Ct scan of abdomen and pelvis without contrast | 12 | $1,274 | $106 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 66 | $814 | $0 |
| Manual urinalysis test with examination using microscope, non-automated | 141 | $780 | $4 |
| Insertion of temporary bladder tube | 14 | $662 | $44 |
| Dxa bone density measurement of hip, pelvis, spine | 11 | $585 | $53 |
| Examination of archival tissue for genetic analysis | 11 | $522 | $47 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 13 | $375 | None |
| Liver function blood test panel | 25 | $267 | $8 |
| Creatinine level to test for kidney function or muscle injury | 24 | $162 | $7 |
| Electronic assessment of bladder emptying | 24 | $154 | $6 |
| Blood creatinine level | 13 | $56 | $4 |
| Urea nitrogen level to assess kidney function, quantitative | 12 | $42 | $4 |
| Injection, ceftriaxone sodium, per 250 mg | 13 | $31 | None |
Medicaid work
$3,909 in 2024
Medicaid paid $3,909 for 982 billed services this clinician did in 2024, up to 45 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 259 | $1,724 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 343 | $1,367 |
| New patient visit (45+ min) | 24 | $719 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 288 | $80 |
| Short return visit (20+ min) | 43 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 25 | $3 |
| 2024 | 982 | 6 | 45 | $3,909 |
| 2023 | 917 | 5 | 53 | $1,918 |
| 2022 | 741 | 9 | 28 | $16,768 |
| 2021 | 1,851 | 12 | 58 | $142,031 |
| 2020 | 1,074 | 10 | 56 | $93,087 |
| 2019 | 2,142 | 16 | 75 | $191,292 |
| 2018 | 1,956 | 18 | 71 | $74,715 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 290 | $1,016 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 256 | $475 |
| New patient visit (45+ min) | 27 | $399 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 330 | $28 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 14 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 64 | $14,342 |
| Return visit (30+ min) | 213 | $1,237 |
| New patient visit (45+ min) | 36 | $540 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 158 | $455 |
| Injection, propofol, 10 mg | 14 | $71 |
| Cefazolin sodium injection | 13 | $51 |
| Injection, ondansetron hydrochloride, per 1 mg | 12 | $36 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 167 | $36 |
| Short return visit (20+ min) | 64 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 663 | $137,593 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 102 | $2,013 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 48 | $916 |
| Short return visit (20+ min) | 530 | $562 |
| Return visit (30+ min) | 377 | $307 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 12 | $297 |
| Ringers lactate infusion, up to 1000 cc | 24 | $121 |
| Cefazolin sodium injection | 30 | $81 |
| Injection, propofol, 10 mg | 15 | $56 |
| Injection, ondansetron hydrochloride, per 1 mg | 26 | $47 |
| Fentanyl citrate injection | 12 | $35 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 12 | $2 |
2020
| Clinic visit/encounter, all-inclusive | 473 | $91,423 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 21 | $627 |
| Short return visit (20+ min) | 356 | $487 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 24 | $243 |
| Short return visit | 110 | $144 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 24 | $65 |
| Fentanyl citrate injection | 12 | $53 |
| Injection, ondansetron hydrochloride, per 1 mg | 13 | $42 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 17 | $2 |
| Return visit (30+ min) | 24 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 939 | $181,004 |
| Service | 107 | $5,875 |
| Service | 99 | $2,977 |
| Fentanyl citrate injection | 100 | $293 |
| Cefazolin sodium injection | 72 | $211 |
| Injection, propofol, 10 mg | 66 | $205 |
| Short return visit | 261 | $190 |
| Ringers lactate infusion, up to 1000 cc | 51 | $181 |
| Injection, ondansetron hydrochloride, per 1 mg | 49 | $131 |
| Injection, midazolam hydrochloride, per 1 mg | 28 | $74 |
| Unclassified drugs | 69 | $62 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 36 | $48 |
2018
| Clinic visit/encounter, all-inclusive | 418 | $65,831 |
| Service | 62 | $4,409 |
| Service | 54 | $1,615 |
| Short return visit (20+ min) | 390 | $1,056 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 104 | $634 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 24 | $334 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 260 | $288 |
| Fentanyl citrate injection | 50 | $144 |
| Injection, ondansetron hydrochloride, per 1 mg | 42 | $109 |
| Injection, propofol, 10 mg | 31 | $95 |
| Cefazolin sodium injection | 29 | $83 |
| Return visit (30+ min) | 19 | $52 |
Drugs they prescribed that Part D paid
$907,374
Pharmacies billed $907,374 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,357 generic and fewer than 11 brand-name prescriptions · $907,374 in drug cost · 311 antibiotic prescriptions to 147 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xtandi | 36 | $487,467 | $13,541 |
| Nubeqa | 21 | $223,573 | $10,646 |
| Myrbetriq | 61 | $39,480 | $647 |
| Orgovyx | 12 | $32,537 | $2,711 |
| Gemtesa | 34 | $19,189 | $564 |
See all 29 drugs
| Xtandi | 36 | $487,467 | $13,541 |
| Nubeqa | 21 | $223,573 | $10,646 |
| Myrbetriq | 61 | $39,480 | $647 |
| Orgovyx | 12 | $32,537 | $2,711 |
| Gemtesa | 34 | $19,189 | $564 |
| Xyosted | 13 | $18,677 | $1,437 |
| Abiraterone Acetate | 17 | $15,816 | $930 |
| Finasteride | 855 | $12,987 | $15 |
| Tamsulosin | 779 | $11,969 | $15 |
| Testosterone | 48 | $3,767 | $78 |
| Nitrofurantoin Mono-Macro | 146 | $3,473 | $24 |
| Dutasteride | 36 | $2,450 | $68 |
| Nitrofurantoin | 43 | $1,531 | $36 |
| Tadalafil | 33 | $1,157 | $35 |
| Silodosin | 11 | $1,099 | $100 |
| Potassium Citrate Er | 12 | $970 | $81 |
| Doxazosin Mesylate | 46 | $695 | $15 |
| Solifenacin | 22 | $538 | $24 |
| Oxybutynin Chloride Er | 15 | $496 | $33 |
| Testosterone Cypionate | 15 | $477 | $32 |
| Terazosin | 14 | $416 | $30 |
| Sildenafil Citrate | 28 | $286 | $10 |
| Sulfamethoxazole-Trimethoprim | 48 | $223 | $5 |
| Oxybutynin Chloride | 16 | $186 | $12 |
| Cephalexin | 28 | $122 | $4 |
| Prednisone | 16 | $120 | $8 |
| Hydroxyzine | 14 | $95 | $7 |
| Ciprofloxacin | 20 | $86 | $4 |
| Allopurinol | 13 | $57 | $4 |
Year by year
| 2024 | 2,607 | 565 | None | None | $907,374 |
| 2023 | 2,152 | 521 | None | None | $1,043,171 |
| 2022 | 2,116 | 490 | None | None | $631,648 |
| 2021 | 2,114 | 481 | None | None | $436,858 |
| 2020 | 2,133 | 484 | None | None | $510,017 |
| 2019 | 2,284 | 515 | 1% (17) | None | $475,044 |
| 2018 | 2,540 | 541 | 1% (32) | None | $649,043 |
| 2017 | 2,804 | 559 | 1% (36) | None | $819,130 |
| 2016 | 2,502 | 531 | 2% (60) | None | $626,806 |
| 2015 | 2,419 | 506 | 2% (36) | 21% | $530,495 |
| 2014 | 2,469 | 508 | 3% (80) | 21% | $381,726 |
| 2013 | 2,286 | 471 | 4% (89) | 18% | $140,171 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Xtandi | 40 | $581,917 | $14,548 |
| Nubeqa | 18 | $217,616 | $12,090 |
| Abiraterone Acetate | 26 | $102,342 | $3,936 |
| Myrbetriq | 57 | $31,113 | $546 |
| Tamsulosin | 648 | $17,722 | $27 |
| Finasteride | 702 | $16,202 | $23 |
| Xyosted | 15 | $13,141 | $876 |
| Gemtesa | 21 | $11,585 | $552 |
| Testosterone | 55 | $10,529 | $191 |
| Dutasteride | 35 | $2,788 | $80 |
| Nitrofurantoin Mono-Macro | 98 | $2,264 | $23 |
| Doxazosin Mesylate | 43 | $1,180 | $27 |
| Nitrofurantoin | 26 | $939 | $36 |
| Tadalafil | 18 | $824 | $46 |
| Oxybutynin Chloride Er | 18 | $658 | $37 |
| Cephalexin | 15 | $274 | $18 |
| Sildenafil Citrate | 21 | $257 | $12 |
| Ciprofloxacin | 34 | $232 | $7 |
| Prednisone | 21 | $204 | $10 |
| Terazosin | 11 | $190 | $17 |
| Sulfamethoxazole-Trimethoprim | 35 | $171 | $5 |
| Oxybutynin Chloride | 11 | $124 | $11 |
2022: 25 drugs
| Xtandi | 24 | $338,837 | $14,118 |
| Nubeqa | 11 | $158,900 | $14,445 |
| Myrbetriq | 65 | $36,412 | $560 |
| Tamsulosin | 661 | $13,879 | $21 |
| Xyosted | 15 | $13,461 | $897 |
| Finasteride | 704 | $12,503 | $18 |
| Abiraterone Acetate | 11 | $8,934 | $812 |
| Testosterone | 27 | $4,257 | $158 |
| Dutasteride | 36 | $3,044 | $85 |
| Nitrofurantoin Mono-Macro | 97 | $2,727 | $28 |
| Bethanechol Chloride | 12 | $2,230 | $186 |
| Silodosin | 20 | $1,878 | $94 |
| Methenamine Hippurate | 12 | $1,007 | $84 |
| Doxazosin Mesylate | 51 | $975 | $19 |
| Solifenacin | 22 | $826 | $38 |
| Cephalexin | 33 | $672 | $20 |
| Sildenafil Citrate | 42 | $479 | $11 |
| Oxybutynin Chloride Er | 18 | $442 | $25 |
| Ketoconazole | 18 | $401 | $22 |
| Nitrofurantoin | 19 | $394 | $21 |
| Oxybutynin Chloride | 17 | $316 | $19 |
| Terazosin | 12 | $198 | $16 |
| Ciprofloxacin | 31 | $176 | $6 |
| Allopurinol | 11 | $170 | $15 |
| Sulfamethoxazole-Trimethoprim | 25 | $154 | $6 |
2021: 24 drugs
| Nubeqa | 13 | $146,179 | $11,245 |
| Xtandi | 12 | $143,278 | $11,940 |
| Myrbetriq | 67 | $38,820 | $579 |
| Abiraterone Acetate | 11 | $15,294 | $1,390 |
| Finasteride | 682 | $14,535 | $21 |
| Tamsulosin | 663 | $12,887 | $19 |
| Xyosted | 14 | $11,679 | $834 |
| Testosterone | 30 | $10,438 | $348 |
| Nitrofurantoin Mono-Macro | 96 | $4,657 | $49 |
| Dutasteride | 36 | $3,040 | $84 |
| Silodosin | 33 | $2,726 | $83 |
| Oxybutynin Chloride Er | 30 | $1,669 | $56 |
| Bethanechol Chloride | 20 | $1,647 | $82 |
| Doxazosin Mesylate | 47 | $993 | $21 |
| Oxybutynin Chloride | 25 | $751 | $30 |
| Tadalafil | 20 | $516 | $26 |
| Sulfamethoxazole-Trimethoprim | 55 | $289 | $5 |
| Nitrofurantoin | 17 | $281 | $17 |
| Cephalexin | 29 | $264 | $9 |
| Ciprofloxacin | 50 | $189 | $4 |
| Ketoconazole | 11 | $168 | $15 |
| Prednisone | 12 | $117 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $86 | $8 |
| Sildenafil Citrate | 12 | $44 | $4 |
2020: 20 drugs
| Abiraterone Acetate | 16 | $88,265 | $5,517 |
| Myrbetriq | 87 | $47,433 | $545 |
| Finasteride | 695 | $12,885 | $19 |
| Tamsulosin | 638 | $11,900 | $19 |
| Testosterone | 27 | $11,845 | $439 |
| Xyosted | 14 | $9,071 | $648 |
| Dutasteride | 41 | $4,406 | $107 |
| Nitrofurantoin Mono-Macro | 87 | $2,913 | $33 |
| Bethanechol Chloride | 19 | $1,557 | $82 |
| Oxybutynin Chloride Er | 31 | $1,437 | $46 |
| Silodosin | 17 | $1,278 | $75 |
| Oxybutynin Chloride | 33 | $1,216 | $37 |
| Doxazosin Mesylate | 48 | $1,053 | $22 |
| Tadalafil | 20 | $1,001 | $50 |
| Nitrofurantoin | 11 | $501 | $46 |
| Solifenacin | 13 | $405 | $31 |
| Ciprofloxacin | 71 | $346 | $5 |
| Cephalexin | 38 | $310 | $8 |
| Sulfamethoxazole-Trimethoprim | 50 | $279 | $6 |
| Prednisone | 23 | $110 | $5 |
2019: 22 drugs
| Abiraterone Acetate | 23 | $134,174 | $5,834 |
| Myrbetriq | 84 | $38,106 | $454 |
| Vesicare | 27 | $16,856 | $624 |
| Finasteride | 709 | $15,167 | $21 |
| Tamsulosin | 658 | $13,499 | $21 |
| Testosterone | 29 | $12,009 | $414 |
| Dutasteride | 52 | $5,294 | $102 |
| Nitrofurantoin Mono-Macro | 127 | $3,895 | $31 |
| Solifenacin | 16 | $3,765 | $235 |
| Silodosin | 23 | $1,644 | $71 |
| Nitrofurantoin | 31 | $1,540 | $50 |
| Doxazosin Mesylate | 55 | $1,319 | $24 |
| Bethanechol Chloride | 19 | $1,268 | $67 |
| Oxybutynin Chloride | 26 | $1,182 | $45 |
| Oxybutynin Chloride Er | 11 | $586 | $53 |
| Cephalexin | 53 | $475 | $9 |
| Sulfamethoxazole-Trimethoprim | 54 | $347 | $6 |
| Prednisone | 31 | $273 | $9 |
| Ciprofloxacin | 43 | $242 | $6 |
| Terazosin | 12 | $159 | $13 |
| Sildenafil Citrate | 11 | $140 | $13 |
| Acetaminophen-Codeine | 17 | $61 | $4 |
2018: 26 drugs
| Xtandi | 23 | $251,149 | $10,920 |
| Zytiga | 17 | $177,580 | $10,446 |
| Vesicare | 79 | $36,945 | $468 |
| Androgel | 41 | $33,474 | $816 |
| Myrbetriq | 70 | $32,201 | $460 |
| Rapaflo | 35 | $17,276 | $494 |
| Tamsulosin | 711 | $15,743 | $22 |
| Finasteride | 753 | $14,150 | $19 |
| Testosterone | 14 | $6,218 | $444 |
| Dutasteride | 68 | $4,392 | $65 |
| Nitrofurantoin Mono-Macro | 121 | $3,320 | $27 |
| Bethanechol Chloride | 28 | $1,852 | $66 |
| Doxazosin Mesylate | 56 | $1,611 | $29 |
| Tolterodine Tartrate Er | 12 | $1,573 | $131 |
| Nitrofurantoin | 29 | $1,190 | $41 |
| Oxybutynin Chloride | 23 | $1,017 | $44 |
| Cephalexin | 74 | $475 | $6 |
| Sulfamethoxazole-Trimethoprim | 69 | $381 | $6 |
| Ciprofloxacin | 46 | $317 | $7 |
| Terazosin | 27 | $228 | $8 |
| Amoxicillin-Clavulanate Potass | 16 | $174 | $11 |
| Prednisone | 20 | $156 | $8 |
| Acetaminophen-Codeine | 17 | $84 | $5 |
| Hydrocodone-Acetaminophen | 14 | $67 | $5 |
| Alprazolam | 11 | $22 | $2 |
| Lorazepam | 14 | $22 | $2 |
2017: 28 drugs
| Zytiga | 35 | $331,336 | $9,467 |
| Xtandi | 25 | $251,937 | $10,077 |
| Androgel | 49 | $43,557 | $889 |
| Myrbetriq | 101 | $41,176 | $408 |
| Vesicare | 68 | $27,360 | $402 |
| Rapaflo | 52 | $25,961 | $499 |
| Tamsulosin | 749 | $22,001 | $29 |
| Finasteride | 798 | $15,188 | $19 |
| Cialis | 22 | $10,679 | $485 |
| Axiron | 12 | $7,014 | $584 |
| Dutasteride | 74 | $6,198 | $84 |
| Nitrofurantoin Mono-Macro | 125 | $3,481 | $28 |
| Bethanechol Chloride | 26 | $2,704 | $104 |
| Doxazosin Mesylate | 69 | $2,264 | $33 |
| Nitrofurantoin | 27 | $2,068 | $77 |
| Tolterodine Tartrate Er | 11 | $1,442 | $131 |
| Oxybutynin Chloride | 32 | $1,437 | $45 |
| Methenamine Hippurate | 14 | $893 | $64 |
| Sulfamethoxazole-Trimethoprim | 92 | $653 | $7 |
| Ciprofloxacin | 57 | $384 | $7 |
| Cephalexin | 66 | $349 | $5 |
| Prednisone | 35 | $248 | $7 |
| Terazosin | 28 | $246 | $9 |
| Amoxicillin-Clavulanate Potass | 19 | $229 | $12 |
| Alfuzosin Hcl Er | 14 | $226 | $16 |
| Hydrocodone-Acetaminophen | 18 | $117 | $7 |
| Acetaminophen-Codeine | 16 | $74 | $5 |
| Alprazolam | 34 | $46 | $1 |
2016: 24 drugs
| Zytiga | 35 | $300,886 | $8,597 |
| Xtandi | 14 | $129,757 | $9,268 |
| Myrbetriq | 97 | $33,793 | $348 |
| Androgel | 35 | $32,471 | $928 |
| Vesicare | 77 | $25,082 | $326 |
| Tamsulosin | 750 | $21,481 | $29 |
| Rapaflo | 54 | $21,406 | $396 |
| Finasteride | 717 | $12,689 | $18 |
| Cialis | 16 | $7,437 | $465 |
| Toviaz | 20 | $7,275 | $364 |
| Dutasteride | 77 | $6,236 | $81 |
| Nitrofurantoin Mono-Macro | 94 | $2,774 | $30 |
| Doxazosin Mesylate | 48 | $1,488 | $31 |
| Nitrofurantoin | 24 | $1,204 | $50 |
| Methenamine Hippurate | 15 | $705 | $47 |
| Ciprofloxacin | 71 | $596 | $8 |
| Desmopressin Acetate | 12 | $532 | $44 |
| Sulfamethoxazole-Trimethoprim | 55 | $520 | $9 |
| Oxybutynin Chloride | 13 | $469 | $36 |
| Hydrocodone-Acetaminophen | 35 | $279 | $8 |
| Prednisone | 35 | $256 | $7 |
| Terazosin | 23 | $202 | $9 |
| Cephalexin | 12 | $149 | $12 |
| Acetaminophen-Codeine | 19 | $125 | $7 |
2015: 27 drugs
| Zytiga | 29 | $224,975 | $7,758 |
| Xtandi | 14 | $123,829 | $8,845 |
| Rapaflo | 100 | $28,574 | $286 |
| Vesicare | 99 | $26,734 | $270 |
| Tamsulosin | 700 | $22,977 | $33 |
| Androgel | 24 | $17,413 | $726 |
| Avodart | 63 | $15,204 | $241 |
| Finasteride | 675 | $10,887 | $16 |
| Myrbetriq | 32 | $9,925 | $310 |
| Axiron | 11 | $6,114 | $556 |
| Toviaz | 22 | $5,818 | $264 |
| Jalyn | 16 | $4,190 | $262 |
| Nitrofurantoin Mono-Macro | 73 | $2,514 | $34 |
| Dutasteride | 16 | $2,335 | $146 |
| Doxazosin Mesylate | 51 | $1,801 | $35 |
| Desmopressin Acetate | 13 | $865 | $67 |
| Nitrofurantoin | 28 | $804 | $29 |
| Ciprofloxacin | 104 | $750 | $7 |
| Methenamine Mandelate | 12 | $737 | $61 |
| Methenamine Hippurate | 13 | $600 | $46 |
| Terazosin | 35 | $378 | $11 |
| Sulfamethoxazole-Trimethoprim | 58 | $364 | $6 |
| Hydrocodone-Acetaminophen | 29 | $274 | $9 |
| Prednisone | 29 | $252 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $147 | $12 |
| Cephalexin | 11 | $75 | $7 |
| Ampicillin Trihydrate | 14 | $53 | $4 |
2014: 28 drugs
| Zytiga | 32 | $230,705 | $7,210 |
| Vesicare | 95 | $23,887 | $251 |
| Avodart | 75 | $16,781 | $224 |
| Rapaflo | 69 | $15,982 | $232 |
| Androgel | 28 | $15,062 | $538 |
| Tamsulosin | 665 | $14,696 | $22 |
| Finasteride | 650 | $10,616 | $16 |
| Toviaz | 31 | $6,296 | $203 |
| Axiron | 12 | $4,911 | $409 |
| Enablex | 17 | $4,200 | $247 |
| Myrbetriq | 17 | $4,162 | $245 |
| Androderm | 11 | $4,160 | $378 |
| Nitrofurantoin Mono-Macro | 86 | $3,673 | $43 |
| Jalyn | 17 | $3,526 | $207 |
| Doxazosin Mesylate | 75 | $2,278 | $30 |
| Nitrofurantoin | 21 | $1,063 | $51 |
| Hydrocodone-Acetaminophen | 70 | $946 | $14 |
| Oxybutynin Chloride | 20 | $898 | $45 |
| Ciprofloxacin | 99 | $779 | $8 |
| Terazosin | 52 | $587 | $11 |
| Oxybutynin Chloride Er | 13 | $563 | $43 |
| Bicalutamide | 18 | $559 | $31 |
| Sulfamethoxazole-Trimethoprim | 79 | $510 | $6 |
| Methenamine Hippurate | 11 | $487 | $44 |
| Amox Tr-Potassium Clavulanate | 18 | $332 | $18 |
| Prednisone | 33 | $330 | $10 |
| Cephalexin | 13 | $109 | $8 |
| Ampicillin Trihydrate | 14 | $80 | $6 |
2013: 19 drugs
| Vesicare | 81 | $19,339 | $239 |
| Rapaflo | 70 | $15,202 | $217 |
| Avodart | 87 | $14,881 | $171 |
| Finasteride | 596 | $13,236 | $22 |
| Tamsulosin | 580 | $10,432 | $18 |
| Androgel | 18 | $8,431 | $468 |
| Nitrofurantoin Mono-Macro | 63 | $2,930 | $47 |
| Enablex | 15 | $2,675 | $178 |
| Detrol La | 12 | $2,403 | $200 |
| Nitrofurantoin | 30 | $1,407 | $47 |
| Doxazosin Mesylate | 101 | $1,310 | $13 |
| Ciprofloxacin | 134 | $918 | $7 |
| Sulfamethoxazole-Trimethoprim | 85 | $595 | $7 |
| Terazosin | 57 | $590 | $10 |
| Hydrocodone-Acetaminophen | 84 | $557 | $7 |
| Oxybutynin Chloride | 22 | $520 | $24 |
| Phenazopyridine | 11 | $169 | $15 |
| Cephalexin | 20 | $157 | $8 |
| Ampicillin Trihydrate | 11 | $49 | $4 |
Money from drug and device companies
$767 in 2025
| 2025 | 19 | 32 | None | $767 |
| 2024 | 14 | 40 | None | $831 |
| 2023 | 12 | 53 | None | $1,618 |
| 2022 | 10 | 18 | None | $366 |
| 2021 | 12 | 21 | None | $474 |
| 2020 | 7 | 8 | None | $142 |
| 2019 | 12 | 37 | None | $549 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Pluvicto | $83 | 3 payments
|
| Janssen Biotech | Erleada | $72 | 3 payments
|
| Tempus AI | Xt Cdx | $64 | 3 payments
|
| Sumitomo Pharma America | Orgovyx | $61 | 3 payments
|
| Blue Earth Diagnostics | Posluma | $57 | 2 payments
|
| Immunitybio | Anktiva | $51 | 2 payments
|
See all 32 published payments
| Teleflex | Meals · 2025-12-16 | Urolift | $38 |
| Dendreon Pharmaceuticals | Meals · 2025-12-16 | Provenge | $31 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Pluvicto | $21 |
| Immunitybio | Meals · 2025-10-30 | Anktiva | $21 |
| Dendreon Pharmaceuticals | Meals · 2025-10-29 | Provenge | $17 |
| Antares Pharma | Meals · 2025-10-24 | Xyosted | $17 |
| Sumitomo Pharma America | Meals · 2025-10-20 | Orgovyx | $22 |
| Progenics Pharmaceuticals | Meals · 2025-10-14 | Pylarify | $21 |
| Caris MPI | Meals · 2025-10-07 | Mi Cancer Seek | $17 |
| Urogen Pharma | Meals · 2025-10-04 | Zusduri | $22 |
| Janssen Biotech | Meals · 2025-09-19 | Erleada | $29 |
| Verity Pharmaceuticals | Meals · 2025-09-12 | Tlando | $14 |
| Immunitybio | Meals · 2025-09-05 | Anktiva | $30 |
| Tempus AI | Meals · 2025-09-04 | Xt Cdx | $20 |
| Antares Pharma | Meals · 2025-08-21 | Xyosted | $19 |
| Novartis Pharmaceuticals | Meals · 2025-08-05 | Pluvicto | $32 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-29 | Nubeqa | $20 |
| Tempus AI | Meals · 2025-07-22 | Xt Cdx | $25 |
| Blue Earth Diagnostics | Meals · 2025-07-08 | Posluma | $28 |
| Tempus AI | Meals · 2025-05-27 | Xt Cdx | $18 |
| Profound Medical | Meals · 2025-05-12 | Tulsa-Pro | $27 |
| Sumitomo Pharma America | Meals · 2025-05-09 | Orgovyx | $19 |
| Ferring Pharmaceuticals | Meals · 2025-05-09 | Adstiladrin | $45 |
| Novartis Pharmaceuticals | Meals · 2025-04-11 | Pluvicto | $30 |
| Verity Pharmaceuticals | Meals · 2025-04-03 | Tlando | $22 |
| Janssen Biotech | Meals · 2025-03-28 | Erleada | $18 |
| Boston Scientific | Meals · 2025-03-28 | Axonics | $17 |
| Blue Earth Diagnostics | Meals · 2025-03-18 | Posluma | $29 |
| Abbvie | Meals · 2025-02-28 | Botox | $34 |
| Myriad Genetic Laboratories | Meals · 2025-02-28 | Prolaris | $18 |
| Janssen Biotech | Meals · 2025-02-06 | Erleada | $25 |
| Sumitomo Pharma America | Meals · 2025-01-30 | Orgovyx | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $831
| Janssen Biotech | Erleada | $165 | 9 payments
|
| Sumitomo Pharma America | Gemtesa | $155 | 9 payments
|
| Immunitybio | Anktiva | $65 | 3 payments
|
| Pfizer | Xtandi | $65 | 3 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $58 | 2 payments
|
| Verity Pharmaceuticals | Trelstar | $58 | 3 payments
|
| Olympus America | Itind System | $44 | 2 payments
|
| Myriad Genetic Laboratories | Prolaris | $38 | 2 payments
|
| Accord Healthcare | Camcevi | $38 | 2 payments
|
| Teleflex | Urolift | $37 | 1 payment
|
| Boston Scientific | Spaceoar Vue System - 10ml | $36 | 1 payment
|
| Novartis Pharmaceuticals | Pluvicto | $29 | 1 payment
|
| Antares Pharma | Xyosted | $25 | 1 payment
|
| Tolmar | Eligard | $19 | 1 payment
|
2023: $1,618
| Myriad Genetic Laboratories | Prolaris | $473 | 5 payments
|
| Janssen Biotech | Erleada | $346 | 13 payments
|
| Endo Pharmaceuticals | Xiaflex | $157 | 1 payment
|
| Pfizer | Xtandi | $155 | 7 payments
|
| Sumitomo Pharma America | Orgovyx | $154 | 7 payments
|
| Antares Pharma | Nocdurna | $136 | 11 payments
|
| Accord Healthcare | Camcevi | $56 | 2 payments
|
| Olympus America | Itind System | $54 | 2 payments
|
| Supernus Pharmaceuticals | Xyosted | $26 | 2 payments
|
| UroGen Pharma | Jelmyto | $23 | 1 payment
|
| Boston Scientific | Spaceoar Vue System - 10ml | $19 | 1 payment
|
| Tolmar | Eligard | $18 | 1 payment
|
2022: $366
| Janssen Biotech | Erleada | $101 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $52 | 2 payments
|
| Abbvie | Lupron Depot | $43 | 2 payments
|
| Urovant Sciences | Gemtesa | $39 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $32 | 2 payments
|
| Myriad Genetic Laboratories | Brac Cdx | $29 | 2 payments
|
| Accord Healthcare | Camcevi | $23 | 1 payment
|
| Olympus America | Itind System | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $14 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $12 | 1 payment
|
2021: $474
| Astellas Pharma US | Xtandi | $106 | 3 payments
|
| Myovant Sciences | Orgovyx | $85 | 4 payments
|
| Janssen Biotech | None | $72 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $45 | 2 payments
|
| Dendreon Pharmaceuticals | Provenge | $30 | 2 payments
|
| Boston Scientific | General Bph | $25 | 1 payment
|
| Antares Pharma | Xyosted | $23 | 1 payment
|
| Pfizer | Xtandi | $23 | 1 payment
|
| Ambu | None | $18 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $17 | 1 payment
|
| Axonics | Axonics R-Snm System | $16 | 1 payment
|
| Teleflex | Urolift System | $14 | 1 payment
|
2020: $142
| Bayer HealthCare Pharmaceuticals | Nubeqa | $30 | 2 payments
|
| Dendreon Pharmaceuticals | Provenge | $27 | 1 payment
|
| Boston Scientific | General - Bph | $23 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $19 | 1 payment
|
| Janssen Biotech | Erleada | $16 | 1 payment
|
| AbbVie | Lupron Depot | $16 | 1 payment
|
| Rochester Medical | None | $11 | 1 payment
|
2019: $549
| Antares Pharma | Xyosted | $173 | 16 payments
|
| Dendreon Pharmaceuticals | Provenge | $78 | 4 payments
|
| Medtronic USA | Interstim Icon | $67 | 3 payments
|
| Astellas Pharma US | Xtandi | $67 | 4 payments
|
| Pfizer | Sutent | $51 | 2 payments
|
| Janssen Biotech | Erleada | $27 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $19 | 1 payment
|
| Boston Scientific | General Bph | $17 | 1 payment
|
| Agiliti Surgical | None | $15 | 1 payment
|
| Ferring Pharmaceuticals | Firmagon | $11 | 1 payment
|
| KARL STORZ Endoscopy-America | Ccu,Modular,Image1 Connect,US | $11 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 79.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1174528178
- Licence
- CA C416810
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00C416810
- Taxonomy
- Urology (208800000X)
- Mailing address
- 7014 N Whitney Ave, Ste A, Fresno, CA, 93720
- NPI first listed
- 2005-06-16
- NPI last updated
- 2012-05-30
This is when the NPI record was last certified, not a medical board exam.